The methyltransferase G9a regulates HoxA9-dependent transcription in AML
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Chromatin modulators are emerging as attractive drug targets, given their widespread implication in human cancers and susceptibility to pharmacological inhibition. Here we establish the histone methyltransferase G9a/EHMT2 as a selective regulator of fast proliferating myeloid progenitors with no discernible function in hematopoietic stem cells (HSCs). In mouse models of acute myeloid leukemia (AML), loss of G9a significantly delays disease progression and reduces leukemia stem cell (LSC) frequency. We connect this function of G9a to its methyltransferase activity and its interaction with the leukemogenic transcription factor HoxA9 and provide evidence that primary human AML cells are sensitive to G9A inhibition. Our results highlight a clinical potential of G9A inhibition as a means to counteract the proliferation and self-renewal of AML cells by attenuating HoxA9-dependent transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“G9a/GLP take part in a number of corepressor complexes, and H3K9me2 is enriched at inactive loci (Barski et al. 2007; Dong et al. 2008) and CpG islands (Lienert et al. 2011).”
BackgroundCancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · cited 4×
“While this would predict a more pronounced sensitivity of IDH1/2 mutant AML cells to inhibitors of G9A/ GLP or other methyltransferases, testing of much larger cohorts of genetically characterized human AML specimens is necessary to substantiate this hypothesis.”
BackgroundInfluentialIDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 2×
“2012), and disruption of the chromatin binding of Brd4 by a BET bromodomain inhibitor blocks c-Myc expression and the proliferation of leukemic cells (Delmore et al. 2011; Zuber et al. 2011).”
BackgroundMutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776 · cited 3×
“2010), and TET2 (Delhommeau et al. 2009) in the pathology of human leukemias has stimulated a great deal of interest in identifying chromatin-modifying enzymes that can be targeted therapeutically (Arrowsmith et al.”
BackgroundTransformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513 · cited 2×
“To investigate G9a function in AML cells, which partially resemble myeloid progenitors (Krivtsov et al. 2006), we generated leukemias from knockout and heterozygous HSPCs by retroviral expression of HoxA9 and Meis1 (A9M) (Supplemental Fig.”
BackgroundEpigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327 · cited 2×
“2009) in the pathology of human leukemias has stimulated a great deal of interest in identifying chromatin-modifying enzymes that can be targeted therapeutically (Arrowsmith et al. 2012; Dawson and Kouzarides 2012).”
BackgroundSchenk, T., Chen, W. C., Göllner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.-U., Popescu, A. C., Burnett, A., Mills, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2661 · Cited by 672 · cited 2×
“Furthermore, LSD1/KDM1A inhibition suppresses acute myeloid leukemia (AML) stem cell activity (Harris et al. 2012; Schenk et al. 2012), and disruption of the chromatin binding of Brd4 by a BET bromodomain inhibitor blocks c-Myc expression and the proliferation of leukemic cells (Delmore et al.”
Background
Research works printed but not linked: 28
- 10.1073/pnas.1213951109 · DOI
- 10.1101/gad.200329.112 · DOI · Paper page
- 10.1016/j.ccr.2011.06.009 · DOI · Paper page
- 10.1016/j.cell.2011.08.017 · DOI · Paper page
- 10.1038/emboj.2008.193 · DOI · Paper page
- 10.1038/leu.2010.171 · DOI
- 10.1016/j.stem.2008.06.002 · DOI · Paper page
- 2009, EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization, Leukemia, 24, 81
- 10.1182/blood-2011-03-341081 · DOI · Paper page
- 10.1093/emboj/17.13.3714 · DOI · Paper page
- 10.1016/j.molcel.2007.01.017 · DOI · Paper page
- 1997, Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis, Blood, 89, 1922, 10.1182/blood.V89.6.1922 · DOI · Paper page
- 10.1038/sj/leu/2401578 · doi:10.1038/sj/leu/2401578
- 10.1182/blood-2005-05-2003 · DOI · Paper page
- 10.1084/jem.20100363 · DOI
- 10.1371/journal.pgen.1002090 · DOI · Paper page
- 10.1021/jm200903z · DOI
- 10.1038/ng.518 · DOI · Paper page
- 10.1016/j.cell.2012.06.048 · DOI · Paper page
- 10.1242/dev.01558 · DOI · Paper page
- 10.1101/gad.989402 · DOI · Paper page
- 10.1101/gad.1284005 · DOI · Paper page
- 10.1182/blood.V99.1.121 · DOI · Paper page
- 10.1016/0092-8674(92)90602-9 · DOI · Paper page
- 10.1038/nchembio.599 · DOI · Paper page
- 10.1038/ng.297 · DOI · Paper page
- 10.1016/S1074-7613(03)00299-1 · DOI · Paper page
- 10.1021/cb300139y · DOI · Paper page
Cited by
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Hamamoto, R., Saloura, V., & Nakamura, Y. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3884 · Cited by 376
Liu, M., Thomas, S. L., DeWitt, A. K., Zhou, W., Madaj, Z. B., Ohtani, H., Baylin, S. B., Liang, G., & Jones, P. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3953 · Cited by 127
“Importantly, G9A, which is responsible for catalyzing mono- or di-methylation of H3K9, is up-regulated in many types of cancers (28-30).”
Jayaram, H., Hoelper, D., Jain, S. U., Cantone, N., Lundgren, S. M., Poy, F., Allis, C. D., Cummings, R., Bellon, S., & Lewis, P. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605523113 · Cited by 92
Saha, N., & Muntean, A. G. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188498 · Cited by 56
Metadata
- Authors
- Lehnertz, B., Pabst, C., Su, L., Miller, M., Liu, F., Yi, L., Zhang, R., Krosl, J., Yung, E., Kirschner, J., Rosten, P., Underhill, T. M., Jin, J., Hébert, J., Sauvageau, G., Humphries, R. K., & Rossi, F. M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-02-14
- Volume
- 28
- Issue
- 4
- Pages
- 317-327
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W4298386872
- Cited by
- 152
- References
- 12
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The methyltransferase G9a regulates HoxA9-dependent transcription in AML. https://app.cochat.ai/papers/10.1101/gad.236794.113
- The paper
- Lehnertz, B., Pabst, C., Su, L., Miller, M., Liu, F., Yi, L., Zhang, R., Krosl, J., Yung, E., Kirschner, J., Rosten, P., Underhill, T. M., Jin, J., Hébert, J., Sauvageau, G., Humphries, R. K., & Rossi, F. M. (2014). The methyltransferase G9a regulates HoxA9-dependent transcription in AML. Genes & Development. https://doi.org/10.1101/gad.236794.113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.